Clinical Trials Browser

Observational × darolutamide × 30 days × Clear all

NCT07395804 2026-05-26

23146

Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

NCT06661122 2026-05-19

HAYATE

Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

NCT07538843 2026-05-15

DARE

Not yet recruiting

Non-metastatic Castration-resistant Prostate Cancer

NCT06334120 2026-05-13

An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea

Non-metastatic Castration-resistant Prostate Cancer